In the present work a new series of 3-alkyl-2,6-diarylpiperidin-4-one-2-thienoyl hydrazones have synthesized by the reaction of 3-alkyl-2, 6-diarylpiperidin-4-one with 2-thiophenecarboxylic acid hydrazide and characterized by spectral (IR, 1 H NMR, 13 C NMR, HSQC, HMBC, NOESY and COSY) techniques. The hydrazones were screened for their in vitro antibacterial and antifungal activities against some selected micro organism. The results show that, compounds with halo-substituents at para position of the phenyl showed good antibacterial profile and antifungal against all tested organism.
Introduction
Heterocyclic ring systems having piperidin-4-one nucleus have aroused great interest in the past and recent years due to their wide variety of biological properties such as antitumor 1, 2 anti-inflammatory 3 central nervous system 4-9 local anaesthetic 10 anticancer 11 and antimicrobial activities 12 and their derivative piperidines are also biologically important and act as neurokinin receptor antogonists 13 , analgesic and antihypertensive agents 14 . The importance of piperidin-4-one as intermediate in the synthesis of a variety of compounds of physiologically active has been reviewed by Prostakov Gaivoronskaya 15 .
Thiophenecarboxylic acid hydrazide have attracted considerable attention due to the biological activity of the 2-thiophene moiety which has been widely recognized and practically applied in several drugs [16] [17] [18] , herbicides 19 and fungicides 20, 21 .
Thiophenecarboxylic hydrazide were tested for antituberculous activity 22 and found to show β-adrenergic blocking activities 23 . Synthesis of molecules, which are novel still resembling known biologically active molecules by virtue of the presence of some critical structural features, is an essential RESEARCH ARTICLE component of the search for new leads in drug designing programme. Certain small heterocyclic molecules act as highly functionalized scaffolds and are known pharmacophores of a number of biologically active and medicinally useful molecules. In the interest of above, we planned to synthesize a system, which combines both bio active piperidine and 2-thiophenecarboxylic acid hydrazide components together to give a title compounds.
Experimental
All the reagents were commercially available and used without further purification. Solvents were distilled from appropriate drying agents immediately prior to use.
Physical measurements
The course of reaction and the purity were ascertained by performing TLC, melting points were determined in open capillaries and are uncorrected. IR spectra were recorded in PerkinElmer 297 spectrophotometer with KBr pellets.
1 H NMR spectra were recorded at 400MHz on Bruker AMX-400MHz spectrophotometer in CDCl 3 using tetramethyl silane (TMS) as internal standard and 13 C NMR spectra were recorded at 100MHz on Bruker AMX400MHz spectrophotometer in CDCl 3 . Elemental analyses (C, H and N) were carried out on a Carlo Erba model 1106 and Perkin Elmer models 240 CHN analyzer. The results are within ±0.4% of the theoretical values. 
Synthesis
From the literature precedent 24 3-alkyl 2,6-diarylpiperidin-4-one (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) were prepared (Scheme 1) by the condensation of appropriate ketones, aldehydes and ammonium acetate in 1:2:1 ratio.
General procedure for the synthesis of 3-alkyl-2,6-diarylpiperidin-4-one-2-thienoyl hydrazone (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) A mixture of 3-alkyl-2,6-diarylpiperidin-4-one (1-14) (1mmol), 2-thiophene-carboxylic acid hydrazide (1.5 mmol) in methanol and chloroform (1:1v/v) and a few drops of acetic acid was added and refluxed for 2-4 hours. On completion of the reaction time, a solid mass was formed, which was then cooled to room temperature. The precipitate was filtered off and washed with ice-cooled water-ethanol mixture. The crude product was recrystallized from ethanol. 
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Antimicrobial activity (Structure-activity relationship)
The new class of compounds in this paper have been preliminarily evaluated for their antibacterial and antifungal activities against a band of certain selected bacterial (Escherichia coli, Salmonella typhi, Staphylococcus aureus, Klebsiella pneumonia and Pseudomonas aeruginosa) and fungal (Aspergillus niger, Aspergillus flavus, Candida albicans and Rhizopus sp.,) pathogens in vitro by conventional twofold serial dilution method 25 . The obtained results were compared to ciprofloxacin and Amphotericin B which were used as the standard drugs for bacterial and fungal strains respectively. The antibacterial and antifungal potencies of the synthesized compounds are reproduced in Table 2 and 3 respectively. Compounds 14 and 20 without any substituent at para position of the aryl moieties at C-2 and C-6 position of the piperidine exhibited antibacterial activity in vitro at 200 µg/mL against all the tested organism except Salmonella typhi and P.aeruginosa. They inhibit both the organism at MIC of 100µg /mL.
Introduction of chloro, bromo and fluoro groups at the para position of the aryl moieties at C-2 and C-6 in piperidine in compound 15, 16 and 18 produced twice the activity against all the organisms. Replacement of halo groups present at the para position of the aryl moieties at C-2 and C-6 of 14 by nitro group yielded moderate activity against all the tested organism except Salmonella typhi and P.aeruginosa.
Introduction of an ethyl groups in place of methyl function in 14 (compound 20) exhibited appreciable inhibition potency towards the tested bacteria strains in the range of 100-200 µg/mL. Introduction of chloro, bromo and fluoro groups at the para position of the aryl moieties at C-2 and C-6 in piperidine in compound 21, 22 and 24 produced antibacterial activity in the range of 12.5-25 µg/mL.
Replacement of halo moieties present at the para position of aryl groups by nitro group (compound 25) produced antibacterial activity in the range of 50-100 µg/mL. Compound 23, which have methyl group at the para position C-2 and C-6 in piperidine ring exhibited antibacterial activity in the region of 100-200 µg/mL.
Antifungal activities
The in vitro antifungal activity of the novel compounds 14-25 were examined against the four fungal strains Aspergillus niger, Aspergillus flavus, Candida albicans and Rhizopus sp., Here, Amphotericin B was used as standard drug.
The compound 14 and 20 without any substituents at the para position of phenyl groups present at the carbon atom adjacent to the heterocyclic nitrogen exhibited antifungal activity in the region 100-200 µg/mL. However, compound 14 against A.niger and 20 against Candida albicans did not show antifungal activity even at a maximum concentration of 200 µg/mL. Compounds 15, 16, 18, 21, 22 and 24, which have electron withdrawing chloro, bromo and fluoro substitution at the para position of phenyl rings attached to C-2 and C-6 carbons of piperdine moiety exerted activity in the region of 12.5-25µg/mL.
Due to introduction of a methyl group in place of the halo function present at the para position of the phenyl groups (compound 17 and 23), the activity was suppressed against all the tested organisms. Introductions of nitro group at the para position of phenyl rings attached to C-2 and C-6 carbons of piperidine moiety shows antifungal activities in the range of 50-100 µg/mL.
Results and Discussion
The obvious synthetic pathway that leads to the title compounds is represented in Scheme 1 structures of all the synthesized compounds were established on the basis of 1 H NMR and 13 C NMR spectral data. The purities of the compounds were checked by elemental analysis. The analytic data agreed well with their proposed molecular formulas.
1 H NMR assignment of compounds 14-25 is made based on their one-and two-dimensional NMR spectral studies. In the 1 H NMR spectra of the target hydrazones, a broad and more downfield D 2 O exchangeable singlet at 9.73 ppm was characteristic of the N-H amide group. The two doublet signal appeared at 3.94 and 3.59 ppm, corresponding to one proton integrals. These two signals are attributed to benzylic protons H 6a and H 2a respectively. However, signals that appeared at 3.31 and 2.25 ppm should be due to the H 5a and H 5e . The methyl proton appeared at 1.09 ppm corresponding to three proton integrals. A triplet appeared at 2.66 ppm due to the H 3a , corresponding to one proton integral. Aromatic protons appeared as a multiplet in the region of 7.06-7.96 ppm. In the 13 C NMR spectrum of compound 15, an absorptions at 13.52 ppm is assigned to methyl carbon at C-3. The benzylic carbon C-2 and C-6 are observed at 69.44 and 60.91 ppm. The 
Conclusion
A close examination of the in vitro antibacterial and antifungal activity profile of the new 2, 6-diaryl piperidin-4-one-2-thienoyl hydrazone against all tested bacterial and fungal organism gives a clear picture about the structure-activity correlations among the compound 14-25 under study. Compounds 14-25 with chloro, bromo and fluoro functions at the para position of the aryl groups present at the C-2 and C-6 position of the piperidine moiety along with methyl and ethyl substituent at the C-3 position exerted a strong activity, while the activity was not significant for compounds 14 and 20 without any substituent at the para position of phenyl groups. Similarly, against the tested fungal strains, compounds 15, 16, 18, 21, 22 and 24 with fluoro, bromo and chloro functions at the para position of phenyl rings attached at C-2 and C-6 carbons of piperidine moiety along with methyl and ethyl substituent at the position C-3 of the piperdine ring exerted a good range of biological activities, while the activity was not significant for compounds 14 and 20 without any substituents at the para position of the phenyl groups.
Furthermore, the observed marked antifungal and antibacterial activities may be considered as key step for the building of novel chemical entities with comparable pharmacological profile to that of the standard drugs.
